Intuitive Biosciences, Inc. — Department of Health and Human Services SBIR Phase I: 115
Intuitive Biosciences, Inc. — SBIR Phase I award from Department of Health and Human Services.
- Amount
- $306,206
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR · Phase I
- Topic
- 115
- Solicitation
- PHS-2023-1
- NAICS
- —
- Place of performance
- WI
- Period
- —
Description
Development of Diagnostics to Differentiate HIV Infection from Vaccine-Induced Seropositivity: The overarching goal of this program is to support the development of new serological and nucleic acid assays that can identify HIV infection while avoiding false-positive results due to vaccine-induced seropositivity (VISP), with high sensitivity and specificity. These next generation assays should be developed to address one or all applications/indications of HIV tests, namely: (1) laboratory based tests; ((2) point-of-care and clinical practices; and (3) self-testing. This contract aims to develop a blood-based, lateral flow HIV diagnostic test that can be employed as point-of-care and as well as for self-testing to differentiate between HIV infection from (VISP).